These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20691268)

  • 1. Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance.
    Larsen CA; Dashwood RH; Bisson WH
    Pharmacol Res; 2010 Dec; 62(6):457-64. PubMed ID: 20691268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
    Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
    Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
    Shimizu M; Shirakami Y; Moriwaki H
    Int J Mol Sci; 2008 Jun; 9(6):1034-1049. PubMed ID: 19325845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
    Nagle DG; Ferreira D; Zhou YD
    Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
    Khan N; Afaq F; Saleem M; Ahmad N; Mukhtar H
    Cancer Res; 2006 Mar; 66(5):2500-5. PubMed ID: 16510563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
    Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
    Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic issues concerning cancer prevention by tea catechins.
    Yang CS; Wang H
    Mol Nutr Food Res; 2011 Jun; 55(6):819-31. PubMed ID: 21538856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea catechins: Proposed mechanisms of action in breast cancer focusing on the interplay between survival and apoptosis.
    Yiannakopoulou ECh
    Anticancer Agents Med Chem; 2014 Feb; 14(2):290-5. PubMed ID: 24069935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.
    Zaveri NT
    Life Sci; 2006 Mar; 78(18):2073-80. PubMed ID: 16445946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents.
    Colomer R; Sarrats A; Lupu R; Puig T
    Curr Drug Targets; 2017; 18(2):147-159. PubMed ID: 26758667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding.
    Kondo T; Ohta T; Igura K; Hara Y; Kaji K
    Cancer Lett; 2002 Jun; 180(2):139-44. PubMed ID: 12175544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
    Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
    Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer chemoprevention with green tea catechins: from bench to bed.
    Shirakami Y; Shimizu M; Moriwaki H
    Curr Drug Targets; 2012 Dec; 13(14):1842-57. PubMed ID: 23140294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.
    Connors SK; Chornokur G; Kumar NB
    Nutr Cancer; 2012; 64(1):4-22. PubMed ID: 22098273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
    Muto S; Fujita K; Yamazaki Y; Kamataki T
    Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
    Jung YD; Ellis LM
    Int J Exp Pathol; 2001 Dec; 82(6):309-16. PubMed ID: 11846837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
    Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
    Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells.
    Namiki K; Wongsirisin P; Yokoyama S; Sato M; Rawangkan A; Sakai R; Iida K; Suganuma M
    Sci Rep; 2020 Feb; 10(1):2444. PubMed ID: 32051483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.
    Zhang Q; Tang X; Lu Q; Zhang Z; Rao J; Le AD
    Mol Cancer Ther; 2006 May; 5(5):1227-38. PubMed ID: 16731755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream carcinogenesis signaling pathways by green tea polyphenols: a translational perspective of chemoprevention and treatment for cancers.
    Hu G; Zhang L; Rong Y; Ni X; Sun Y
    Curr Drug Metab; 2014 Jan; 15(1):14-22. PubMed ID: 24329111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.